Coach vs. Kors: Bat...
Health Care: Health Services
DexCom Inc. (DXCM: NASDAQ)
$10.71 -0.06 | -0.56%
06/04/12 - 09:54 AM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 10.77 |
| 52 Week High | 15.77 |
| 52 Week Low | 6.75 |
| Avg. Daily Vol. (Mil) | 0.44 |
| Beta (3 year) | 0.30 |
| Share Related Items | |
| Mkt Cap (Mil) | 738.28 |
| Shares Out (Mil) | 68.55 |
| Float (Mil) | 67.24 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.10 |
| Current Ratio | 5.80 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 8.98 |
| Price/Book | 7.42 |
| Price/Cash Flow | -17.70 |
| Per Share Data | |
| Earnings | -0.70 |
| Sales | 1.20 |
| Book Value | 1.45 |
| Cash Flow | -0.61 |
| Business Summary | |
|---|---|
| Dexcom, Inc. is designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. | |
| General Information | |
| 6340 Sequence Drive
San Diego, CA 92121 |
|
| www.dexcom.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 502 | |
| CEO: Terrance H. Gregg | |
| Short Interest | |
| Current Month (Mil) | 6.40 |
| Previous Month (Mil) | 6.16 |
| Short Interest Ratio (Days) | 14.50 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -39.80 |
| Return on Investments | -47.00 |
| Profitability | |
| Gross Margin | 55.10 |
| EBIT Margin | -58.70 |
| Profit Margin | -57.10 |
Portfolios with DXCM
- Portfolio NameUser Type
- ContributorUnder-$10 Setting Up To Tra...
- UserWatch 1 - Breakout
- ContributorBreakout Stocks Of The Week...
- ContributorBarron's Insider Purchases ...
- UserPART 3 JPMorgan 28th Annual...
- UserLast Day of the JPMorgan He...
- UserPART 7 JPMorgan 26th Annual...
- Userheld_2long
- Userusa9 Portfolio 1
- UserSyOps Portfolio 1
Latest DXCM Headlines from TheStreet
- 5 Under-$10 Stocks Set to Soar 12.29.11 | 06:12 pm
- DexCom Stock Hits New 52-Week Low (DXCM) 11.21.11 | 10:11 am
- DexCom Stock Hits New 52-Week Low (DXCM) 11.08.11 | 10:11 am
- DexCom Stock Gaps Down On Today's Open (DXCM) 11.03.11 | 09:11 am
- DexCom Stock Hits New 52-Week Low (DXCM) 10.27.11 | 02:10 pm
- DexCom Stock Falls On Unusually High Volume (DXCM) 08.04.11 | 02:08 pm
- DexCom Stock Falls On Unusually High Volume (DXCM) 05.05.11 | 01:05 pm
- DexCom CEO Discusses Q3 2010 Results - Earnings Call Transcript 11.07.10 | 02:11 pm
- Breakout Stocks: SPDR Gold Trust, Netflix 08.16.10 | 03:08 pm
- DexCom, Inc.Q2 2010 Earnings Call Transcript 08.04.10 | 01:08 am
Press Releases for DXCM
- Dexcom To Present At The Deutsche Bank 37th Annual Healthcare Conference - Business Wire 04.26.12 | 08:04 am
- Dexcom Schedules First Quarter 2012 Earnings Release And Conference Call For May 2, 2012 - Business Wire 04.25.12 | 08:04 am
- Dexcom To Present At The Barclays Capital Global Healthcare Conference - Business Wire 03.06.12 | 08:03 am
- DexCom, Inc. Reports Fourth Quarter And Full Year 2011 Financial Results - Business Wire 02.23.12 | 04:02 pm
- DexCom, Inc. Announces Acquisition Of SweetSpot Diabetes Care, Inc. - Business Wire 02.23.12 | 04:02 pm
- Dexcom Schedules Fourth Quarter And Full Year 2011 Earnings Release And Conference Call For February 23, 2012 - Business Wire 02.14.12 | 09:02 am
- DexCom And Tandem Diabetes Care Announce CGM Development And Commercialization Agreement - Business Wire 02.02.12 | 08:02 am
- Dexcom To Present At The 30th Annual J.P. Morgan Healthcare Conference - Business Wire 01.03.12 | 04:01 pm
- DexCom To Present At Upcoming Investor Conferences - Business Wire 11.07.11 | 04:11 pm
- DexCom To Present At Upcoming Investor Conferences - Business Wire 11.07.11 | 05:11 am
Partner Headlines for DXCM
- DexCom Misses on EPS, Losses Mount - Analyst Blog - Zacks 05.07.12 | 10:05 am
- UPDATE: Brean Murray Carret Raises Target on DexCom to $13.50 - Benzinga 02.24.12 | 04:02 pm
- UPDATE: Wunderlich Securities Raises Price Target on DexCom to $15 - Benzinga 02.24.12 | 09:02 am
- UPDATE: Feltl & Co Upgrades DexCom from Hold to Buy and Lowers PT from $15.85 to $15.35 - Benzinga 08.16.11 | 09:08 am
- DexCom Reaffirmed Neutral - Analyst Blog - Zacks 05.26.11 | 06:05 pm
- Contrarian Ideas: 20 Healthcare Stocks With Low Put/Call Ratios - Seeking Alpha 01.18.11 | 07:01 am
- DexCom shares plunge after FDA seeks more data on products - Reuters 11.05.10 | 12:11 pm
- William Blair Reiterates Outperform on DexCom (DXCM) - Benzinga 08.04.10 | 09:08 am
- M&A Market: Potential Acquisition Plays in Each Sector - Seeking Alpha 07.06.10 | 06:07 am
- DexCom Misses Zacks Consensus - Analyst Blog - Zacks 05.13.10 | 02:05 pm
